José Miguel Montejo

ORCID: 0000-0001-7432-0830
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bacterial Identification and Susceptibility Testing
  • Antimicrobial Resistance in Staphylococcus
  • Antibiotic Resistance in Bacteria
  • Antifungal resistance and susceptibility
  • Renal Transplantation Outcomes and Treatments
  • Neutropenia and Cancer Infections
  • Organ Transplantation Techniques and Outcomes
  • Hepatitis C virus research
  • Legionella and Acanthamoeba research
  • Streptococcal Infections and Treatments
  • Transplantation: Methods and Outcomes
  • HIV/AIDS Research and Interventions
  • Influenza Virus Research Studies
  • Cytomegalovirus and herpesvirus research
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotic Use and Resistance
  • HIV Research and Treatment
  • Assisted Reproductive Technology and Twin Pregnancy
  • T-cell and Retrovirus Studies
  • HIV-related health complications and treatments
  • Microbial Metabolism and Applications
  • Fungal Infections and Studies
  • Antimicrobial Peptides and Activities
  • Burkholderia infections and melioidosis
  • Plant Pathogenic Bacteria Studies

Hospital de Cruces
2003-2022

Instituto de Salud Carlos III
2019-2021

Red Espanola de Investigacion en Patologia Infecciosa
2019-2021

University of the Basque Country
2018

BioCruces Health research Institute
2017

10.1016/j.cmi.2016.05.004 article EN publisher-specific-oa Clinical Microbiology and Infection 2016-05-13

Influenza vaccine effectiveness is not optimal in solid organ transplant recipients (SOTR). We hypothesized that a booster dose might increase it.TRANSGRIPE 1-2 phase 3, randomized, controlled, multicenter, open-label clinical trial. Patients were randomly assigned (1:1 stratified by study site, type of organ, and time since transplantation) to receive 1 (control group) or 2 doses (booster the influenza 5 weeks apart.A total 499 SOTR enrolled. Although seroconversion at 10 did meet...

10.1093/cid/ciw855 article EN Clinical Infectious Diseases 2017-02-22

This report describes the results of six antimicrobial regimens used for treatment brucellosis in an open, randomized study performed over two periods (1980–1983 and 1984–1987). In first period, rifampicin doxycycline were 4 weeks, trimethoprim-sulfamethoxazole 6 months, weeks. During second we streptomycin 2 or 3 weeks together with Comparison showed following: (1) no statistically significant findings revealed when different compared (2) containing yielded more favorable than those...

10.1093/clind/16.5.671 article EN Clinical Infectious Diseases 1993-05-01
António Ramos Patricia Muñóz Arístides de Alarcón González Patricia Muñóz Ana Fernández‐Cruz and 95 more Maricela Valerio María Carmen Fariñas Manuel Gutiérrez‐Cuadra José Ma Miró Josefa Ruiz‐Morales Dolores Sousa-Regueiro José Miguel Montejo Juan Gálvez-Acebal Carmen Hidalgo-Tenorio Fernándo Domínguez Fernando Fernández Sánchez Mariam Noureddine Gabriel Rosas Javier de la Torre José I. Aramendi Elena Bereciartúa Roberto Blanco María Victoria Boado Itxasne Cabezón Estébanez Marta Campaña Lázaro Josune Goikoetxea J.J. Goiti José Ramón Iruretagoyena Josu Irurzun Zuazabal Leire López-Soria Miguel Montejo Javier Nieto David Rodríguez Regino Rodríguez Roberto Voces Ma Victoria García López Radka Ivanova Georgieva Guillermo Ojeda Isabel Rodríguez Bailón Josefa Ruíz Morales Ana María Cuende Tomás Echeverría Ana Fuerte Eduardo Gaminde Miguel Ángel Goenaga Pedro Idígoras José Antonio Iribarren Alberto Izaguirre Yarza Xabier Kortajarena Urkola Carlos Reviejo Rafael Carrasco Vicente Climent Patricio Llamas Esperanza Merino Joaquín Plazas Sergio Reus Nemesio Álvarez José María Bravo-Ferrer Laura Castelo José J. Cuenca‐Castillo Pedro Llinares Enrique Míguez Rey María Rodríguez Mayo Efrén Sánchez Dolores Sousa F.J. Martínez-Moreno M.M. Alonso Beatriz Castro Dácil García Rosado Ma del Carmen Durán Ma Antonia Miguel Gómez Juan Lacalzada‐Almeida Ibrahim Nassar Antonio Pláta Ciézar José Ma Reguera Iglesias Víctor Asensi Carlos Costas Jesús de la Hera Jonathan Fernández-Suárez Lisardo Iglesias Fraile Víctor León José López Menéndez Pilar Mencía Bajo Carlos Morales Alfonso Moreno Torrico Carmen Palomo B. Martínez Ángeles Rodríguez Esteban Raquel Rodríguez-García Mauricio Telenti Asensio Manuel Almela Juan Ambrosioni Manuel Azqueta Merçè Brunet Marta Bodro Ramón Cartañá Carlos Falces Guillermina Fita David Fuster Cristina García de la Mària

10.1016/j.jiac.2018.03.003 article EN Journal of Infection and Chemotherapy 2018-04-06

We aimed to analyze whether the lack of inclusion specific recommendations for management candidemia is an independent risk factor early and overall mortality. Multicenter study adult patients with in 13 hospitals. assessed proportion on whom nine ESCMID IDSA guidelines had been applied, analyzed its impact 455 episodes were documented. Patients who died within first 48 hours excluded. Sixty-two percent received appropriate antifungal treatment. Either echinocandin or amphotericin B therapy...

10.1093/mmy/myy118 article EN Medical Mycology 2018-10-26

In contrast with HIV-1, information about drug resistance in HIV-2 is scarce and mainly derived from small series of patients failing antiretroviral therapy. The spectrum changes the reverse transcriptase (RT), protease (PR) integrase (INT) genes was examined individuals enrolled Spanish register. From a total 236 HIV-2-infected registered Spain 1989 to June 2010, 53 PR, 44 RT 8 INT sequences were obtained. Low plasma viraemia precluded collection this most remaining cases. No major...

10.1093/jac/dkr164 article EN Journal of Antimicrobial Chemotherapy 2011-05-10

Whether echinocandins could be used to treat candidemia of a urinary tract source (CUTS) is unknown. We aimed provide current epidemiological information CUTS and compare echinocandin fluconazole treatment on outcomes.A multicenter study adult patients with was conducted in 9 hospitals. defined as concomitant candiduria by the same organism associated significant urological comorbidity. The primary outcome assessed clinical failure (defined 7-day mortality or persistent candidemia) treated...

10.1093/cid/cix033 article EN Clinical Infectious Diseases 2017-01-30

The diagnosis of invasive aspergillosis (IA) can be problematic in solid organ transplantation (SOT). prognosis greatly varies according to the type transplant, and impact prophylaxis is not well defined.The Diaspersot cohort analyses IA SOT Spain during last 10 years. Proven probable/putative was included.We analysed 126 cases IA. incidences were as follows: 6.5%, 2.9%, 1.8% 0.6% for lung, heart, liver kidney transplantation, respectively. EORTC/MSG criteria confirmed only 49.7% episodes....

10.1111/myc.13298 article EN Mycoses 2021-05-02

10.1016/j.jinf.2015.12.009 article EN Journal of Infection 2015-12-24

To assess the effect of combination antibiotic empirical therapy on 30-day case-fatality rate in neutropenic cancer patients with Pseudomonas aeruginosa (PA) bacteremic pneumonia. This was a multinational, retrospective cohort study onco-hematological PA bloodstream infection (BSI) (2006−2018). The appropriate therapy, monotherapy and inappropriate [IEAT] assessed only Among 1017 BSI episodes, pneumonia source 294 (28.9%). those, 52 (17.7%) were caused by multidrug-resistant (MDR) strain 68...

10.3390/microorganisms10040733 article EN cc-by Microorganisms 2022-03-29

Abstract The objective of this study was to analyse the mechanisms resistance carbapenems and other extended-spectrum-β-lactams determine genetic relatedness multidrug-resistant Enterobacterales (MDR-E) causing colonization or infection in solid-organ transplantation (SOT) recipients. Prospective cohort kidney (n = 142), liver 98) kidney/pancreas 7) transplant recipients between 2014 2018 seven Spanish hospitals. We included 531 MDR-E isolates from rectal swabs obtained before weekly for 4–6...

10.1038/s41598-021-90382-5 article EN cc-by Scientific Reports 2021-06-04
Lourdes Roc Carmen de Mendoza Miriam Fernández‐Alonso Gabriel Reina Vincent Soriano and 95 more Conrado Fernández‐Rodríguez Mar Vera Jorge del Romero Goizane Marcaida María Dolores Ocete E. Caballero Israel Molina A. Aguilera José Javier Rodríguez Daniel Navarro Cecilia Rivero M.D. Vilariño Rafael Benito Sonia Algarate Joan Gil Raúl Ortíz de Lejarazu S Rojo José Marı́a Eiros Bouza A. San Miguel Christian Manzardo José M. Miró J.H. de Gea-García I. Paz Eva Poveda Enrique J. Calderón Domingo Escudero M.M. Trigo José Carlos Diz Marta García‐Campello Manuel Rodríguez‐Iglesias A. Hernández-Betancor Anna Martin José Manuel Ramos Adelina Gimeno Félix Gutiérrez Juan Carlos Rodrı́guez V. Sánchez Sánchez César Gómez-Hernando Gustavo Cilla E. Pérez-Trallero José López‐Aldeguer Luis Fernández-Pereira Jordí Niubó María José Hernández A. López-Lirola Juan Luís Gómez-Sirvent Lluís Force Celia Cifuentes Salvador Pérez Luís Morano Carmen Raya Alejandro González‐Praetorius J.L. Pérez María Luz Pintos Peñaranda Silvia Hernáez-Crespo José Miguel Montejo Lourdes Roc Ana Martínez-Sapiña Isabel Viciana Teresa Cabezas Alejandro Lozano Juan Manuel Fernández Isabel García-Bermejo G. Gaspar R. García Miguel Górgolas Carlos del Pozo Vegas José Blas Pilar Miralles Miguel González Valeiro Teresa Aldámiz N Margall C. Guardià Elaine Pico Inmaculada Ortiz Polo A. Aguinaga Carmen Ezpeleta Silvia Sauleda María Pirón Ruperto González‐Pérez Luisa Barea Antonio Jiménez Lidia Rodríguez Blanco A. Suárez Iciar Rodríguez-Avial Alfredo Pérez‐Rivilla Patricia Parra M. Fernández Miriam Fernández‐Alonso Gabriel Reina Ana Treviño Silvia Requena Laura Benítez‐Gutiérrez Valentín Cuervas‐Mons Carmen de Mendoza

Two kidney transplant recipients from a single donor became infected with HTLV-1 (human T-lymphotropic virus type 1) in Spain. One developed myelopathy 8 months following surgery despite early prescription of antiretroviral therapy. The allograft was removed the second recipient at month due to rejection and immunosuppressors discontinued. To date, 3 years later, this patient remains but asymptomatic. infection recognized retrospectively donor, native Spaniard who had sex partners endemic...

10.1177/2049936119868028 article EN cc-by-nc Therapeutic Advances in Infectious Disease 2019-01-01

Despite administration of annual influenza vaccination, influenza-associated complications in transplant recipients continue to be an important cause hospitalization and death. Although vaccination has been proven the most effective measure reduce infection after transplantation, are still vulnerable infections, with lower serological responses compared general population. In order assess efficacy safety alternative immunization scheme for solid organ recipients, TRANSGRIPE1-2 Study Group...

10.1186/1745-6215-15-338 article EN cc-by Trials 2014-08-28

Abstract Background Daptomycin plus fosfomycin combination has demonstrated synergistic and bactericidal effect in animal models of methicillin-resistant Staphylococcus aureus bacteremia (MRSAB), but there is lack data humans. Method A randomized (1:1), open-label, clinical trial involving adults with MRSAB was conducted at 18 medical centers Spain. Patients were assigned to receive daptomycin, 10 mg/kg IV daily fosfomycin, 2 g IV/6 hour (combination therapy) or daptomycin mg/kg/24 h...

10.1093/ofid/ofy229.2177 article EN cc-by-nc-nd Open Forum Infectious Diseases 2018-11-01

HIV-2 infection is characterized by low plasma viraemia and slower progression to AIDS in comparison with HIV-1 infection. However, antiretroviral therapy patients less effective often fails provide optimal CD4 recovery.We examined viral tropism persons enrolled the Spanish cohort. Viral was estimated based on V3 sequences obtained from RNA and/or proviral DNA.From a total of 279 individuals recorded national register, 58 belonging 42 were evaluated. X4 viruses recognized 14 (33%). Patients...

10.1093/jac/dku119 article EN Journal of Antimicrobial Chemotherapy 2014-04-30

Pseudomonas aeruginosa (PA) has historically been one of the major causes severe sepsis and death among neutropenic cancer patients. There a recent increase multidrug-resistant PA (MDRPA) isolates that may determine worse prognosis, particularly in immunosuppressed The aim this study is to establish impact antibiotic resistance on outcome onco-haematological patients with bacteraemia, identify risk factors for MDRPA bacteraemia mortality. This retrospective, observational, multicentre,...

10.1136/bmjopen-2018-025744 article EN cc-by-nc BMJ Open 2019-05-01

Objective Successful clinical trials are subject to recruitment. Recently, the REJUVENATE trial, a prospective phase 2a open-label, single-arm interventional trial conducted within Innovative Medicines Initiative-supported Combatting Bacterial Resistance in Europe-Carbapenem project, was published, with 85% of recruitment performed Spain. We analysed success this by establishing model practice. Methods A descriptive qualitative study from May 2016 October 2017 at 10 participating Spanish...

10.1136/bmjopen-2021-051187 article EN cc-by-nc BMJ Open 2022-02-01
Coming Soon ...